SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 202 filers reported holding SAGE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $151,269 | +999.7% | 13,929 | +1797.7% | 0.00% | – |
Q1 2024 | $13,755 | -82.7% | 734 | -80.0% | 0.00% | -100.0% |
Q4 2023 | $79,486 | -23.5% | 3,668 | -27.4% | 0.00% | -66.7% |
Q3 2023 | $103,929 | -23.8% | 5,050 | +74.0% | 0.00% | -40.0% |
Q2 2023 | $136,452 | +104863.1% | 2,902 | -6.5% | 0.01% | +25.0% |
Q1 2023 | $130 | +293.9% | 3,103 | +257.1% | 0.00% | +300.0% |
Q4 2022 | $33 | -100.0% | 869 | -92.1% | 0.00% | -85.7% |
Q3 2022 | $432,000 | -37.8% | 11,019 | -48.8% | 0.01% | -56.2% |
Q2 2022 | $695,000 | +11.7% | 21,532 | +14.6% | 0.02% | +166.7% |
Q1 2022 | $622,000 | +49.9% | 18,794 | +92.4% | 0.01% | -14.3% |
Q4 2021 | $415,000 | +57.2% | 9,768 | +63.8% | 0.01% | 0.0% |
Q3 2021 | $264,000 | +417.6% | 5,963 | +565.5% | 0.01% | +600.0% |
Q2 2021 | $51,000 | -31.1% | 896 | -9.7% | 0.00% | 0.0% |
Q1 2021 | $74,000 | -88.5% | 992 | -86.7% | 0.00% | -95.0% |
Q4 2020 | $646,000 | +466.7% | 7,469 | +299.0% | 0.02% | +1900.0% |
Q3 2020 | $114,000 | -32.1% | 1,872 | -53.8% | 0.00% | -85.7% |
Q2 2020 | $168,000 | +7.0% | 4,051 | +85.7% | 0.01% | -46.2% |
Q4 2019 | $157,000 | +137.9% | 2,181 | +364.0% | 0.01% | +160.0% |
Q3 2019 | $66,000 | -40.5% | 470 | -22.7% | 0.01% | -28.6% |
Q2 2019 | $111,000 | +593.8% | 608 | +424.1% | 0.01% | +600.0% |
Q3 2018 | $16,000 | -82.4% | 116 | -80.1% | 0.00% | -80.0% |
Q2 2018 | $91,000 | -73.5% | 582 | -89.5% | 0.01% | -82.1% |
Q3 2017 | $344,000 | +11366.7% | 5,525 | +5212.5% | 0.03% | – |
Q2 2016 | $3,000 | -97.3% | 104 | -96.0% | 0.00% | -100.0% |
Q3 2015 | $110,000 | +54.9% | 2,592 | +167.2% | 0.01% | +83.3% |
Q2 2015 | $71,000 | +1083.3% | 970 | +663.8% | 0.01% | +500.0% |
Q1 2015 | $6,000 | – | 127 | – | 0.00% | – |
Q4 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q3 2014 | $8,000 | – | 252 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |